|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
5,524,000 |
Market
Cap: |
578.92(M) |
Last
Volume: |
26,007 |
Avg
Vol: |
40,429 |
52
Week Range: |
$84.55 - $143.36 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
500 |
Total Buy Value |
$0 |
$0 |
$0 |
$100,000 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
1,500 |
10,500 |
35,989 |
Total Sell Value |
$0 |
$168,540 |
$1,317,035 |
$6,085,887 |
Total People Sold |
0 |
1 |
3 |
7 |
Total Sell Transactions |
0 |
1 |
5 |
23 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sullivan John James |
Director |
|
2022-11-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,425 |
42,812 |
|
- |
|
Schmieder John Bradley |
Director |
|
2022-11-11 |
4 |
S |
$175.45 |
$438,625 |
D/D |
(2,500) |
68,976 |
|
5% |
|
Guillemin Evan |
Director |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
431 |
29,207 |
|
- |
|
Alltoft Jennifer Sadie |
Director |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
431 |
1,646 |
|
- |
|
Hall Shannon |
Director |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
431 |
1,187 |
|
- |
|
Sakys John V |
CFO |
|
2022-09-01 |
4 |
D |
$178.42 |
$142,558 |
D/D |
(799) |
9,696 |
|
- |
|
Sakys John V |
CFO |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,817 |
10,495 |
|
- |
|
Archbold Brian David |
VP Operations |
|
2022-09-01 |
4 |
D |
$178.42 |
$73,509 |
D/D |
(412) |
1,304 |
|
- |
|
Archbold Brian David |
VP Operations |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
903 |
1,716 |
|
- |
|
Schmieder John Bradley |
Director |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
431 |
71,476 |
|
- |
|
Sullivan John James |
Director |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
787 |
44,237 |
|
- |
|
Owens Gary M |
President and CEO |
|
2022-09-01 |
4 |
D |
$178.42 |
$128,819 |
D/D |
(722) |
26,586 |
|
- |
|
Owens Gary M |
President and CEO |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,668 |
27,308 |
|
- |
|
Guillemin Evan |
Director |
|
2022-08-18 |
4 |
S |
$196.12 |
$724,075 |
D/D |
(3,692) |
28,776 |
|
16% |
|
Guillemin Evan |
Director |
|
2022-08-18 |
4 |
OE |
$70.56 |
$267,063 |
D/D |
2,680 |
32,468 |
|
- |
|
Sakys John V |
CFO |
|
2022-08-16 |
4/A |
AS |
$200.58 |
$275,196 |
D/D |
(1,372) |
8,678 |
|
- |
|
Sakys John V |
CFO |
|
2022-08-16 |
4 |
S |
$200.58 |
$275,196 |
D/D |
(1,372) |
8,678 |
|
19% |
|
Sakys John V |
CFO |
|
2022-08-16 |
4 |
OE |
$70.56 |
$96,808 |
D/D |
1,372 |
10,678 |
|
- |
|
Sakys John V |
CFO |
|
2022-08-15 |
4 |
S |
$200.54 |
$125,939 |
D/D |
(628) |
10,050 |
|
19% |
|
Sakys John V |
CFO |
|
2022-08-15 |
4 |
OE |
$70.56 |
$44,312 |
D/D |
628 |
9,306 |
|
- |
|
Ladiwala Shiraz Shabanali |
Director |
|
2022-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
405 |
405 |
|
- |
|
Tripeny R Tony |
Director |
|
2022-08-09 |
4 |
B |
$200.00 |
$100,000 |
D/D |
500 |
500 |
2.39 |
-15% |
|
Sullivan John James |
Director |
|
2022-07-05 |
4 |
OE |
$70.56 |
$2,092,223 |
D/D |
18,576 |
43,450 |
|
- |
|
Owens Gary M |
President and CEO |
|
2022-06-21 |
4 |
S |
$188.22 |
$330,521 |
D/D |
(1,756) |
21,640 |
|
30% |
|
Owens Gary M |
President and CEO |
|
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,055 |
23,396 |
|
- |
|
453 Records found
|
|
Page 3 of 19 |
|
|